News

FDA to undo some layoffs, after cuts to inspections and drug safety
Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...
Axios on MSN4h
FDA to query compounding pharmacies amid safety concerns
The Food and Drug Administration plans to survey compounding pharmacies that make specialized copies of prescription drugs ...
STAT1d
Will the FDA approve the first new drug to help people quit smoking in 20 years?
The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...
JD Supra21h
HHS and FDA Announce Plans to Phase Out Certified Colors
On April 22, 2025, the U.S. Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA) announced a series of ...
Ophthalmology Times47m
FDA grants fast track designation to OKYO Pharma’s urcosimod for treatment of neuropathic corneal pain
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
STAT2d
Amid FDA chaos, approval of a rare disease drug gets delayed — again
Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...
BioPharma Dive20h
J&J secures FDA OK for immune drug touted as future blockbuster
The company has predicted that Imaavy — now approved for myasthenia gravis — could eventually earn more than $5 billion in ...
JD Supra2d
The FDA Removes Semaglutide from the Drug Shortage List
The Food and Drug Administration (“FDA”) has removed semaglutide from its drug shortage list after the agency determined the current supply of ...
Trump administration officials banned chosen names at FDA, NIH under new gender policy
Health and Human Services employees were told in March to remove nicknames from email systems and signatures to comply with Trump order on gender.
American Council on Science and Health2hOpinion
FDA in Crisis: How Trump Administration Downsizing Is Slowing Medical Innovation and Endangering Public Health
Recent reorganizations and "reductions in force" at the FDA have damaged the very backbone of our public health system.